Clinical Trials
2 trialsNCT06162377 2025-12-17
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
M.D. Anderson Cancer Center
Phase 4 Recruiting
NCT01004393 2016-02-02
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
University of Vermont
Phase 2 Completed